University of Paris 5 - René Descartes / Université Paris V René Descartes

University / College

Location: Paris, France (FR) FR

ISNI: 000000121880914


Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year




Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region. (2023) Lescoat A, Huscher D, Schoof N, Airo P, De Vries-Bouwstra J, Riemekasten G, Hachulla E, et al. Journal article Subclinical Left Ventricular Dysfunction Detected by Speckle-Tracking Echocardiography in Breast Cancer Patients Treated With Radiation Therapy: A Six-Month Follow-Up Analysis (MEDIRAD EARLY‐HEART study) (2022) Locquet M, Spoor D, Crijns A, Van Der Harst P, Eraso A, Guedea F, Fiuza M, et al. Journal article Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment (2022) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Journal article Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort. (2022) Zanatta E, Huscher D, Ortolan A, Avouac J, Airo P, Balbir-Gurman A, Siegert E, et al. Journal article The Attitudes of European Medical Students towards the Clinical Importance of Neuroanatomy (2022) Moxham BJ, Brenner E, Plaisant O, Pais D, Stabile I, Scholz M, Paulsen F, et al. Journal article Safety and effectiveness of pediatric growth hormone therapy: Results from the full cohort in KIGS (2021) Maghnie M, Ranke MB, Geffner ME, Vlachopapadopoulou E, Dörr HG, Wikland KA, Ibanez L, et al. Conference contribution Risk-Adjusted Cancer Screening and Prevention (RiskAP): complementing screening for early disease detection by a learning screening based on risk factor (2021) Schmutzler RK, Schmitz-Luhn B, Borisch B, Devilee P, Eccles D, Hall P, Balmaña J, et al. Journal article, Original article EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT (2021) Kuster S, Jordan S, Elhai MD, Held U, Steigmiller K, Bruni C, Iannone F, et al. Conference contribution PATIENT PREFERENCES, TRADE-OFFS AND ACCEPTABLE RISKS IN THE TREATMENT OF SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A STEP TOWARDS SHARED DECISION-MAKING (2021) Bruni C, Heidenreich S, Duenas A, Hoffmann-Vold AM, Gabrielli A, Allanore Y, Chatelus E, et al. Conference contribution Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. (2021) Hoffmann-Vold AM, Allanore Y, Alves M, Brunborg C, Airo P, Ananieva LP, Czirjak L, et al. Journal article